Xu Huang
180 Fenglin Road
Zhongshan, China
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The surrogacy of disease-free survival for overall survival in locally advanced esophageal squamous cell carcinoma after neoadjuvant therapy.
Journal: International journal of clinical oncology
Published: January 12, 2026
DUSP5 suppresses esophageal squamous cell carcinoma by counteracting macrophage-derived AREG-ERK1/2 signaling and disrupting an oncogenic ERK1/2-ELK1-DUSP5 feedback circuitry.
Journal: Cell death & disease
Published: August 22, 2025
RCN2 facilitates esophageal squamous cellular carcinoma metastasis and cisplatin resistance through UBR5-mediated PPP2CA ubiquitination and degradation.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: August 01, 2025
Primary Tumour Burden Score: A Novel Staging Parameter for Oesophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: February 02, 2025
Identification and validation of poor prognosis immunoevasive subtype of esophageal cancer with tumor-infiltrating SAMD3 + NK cell abundance.
Journal: Cancer immunology, immunotherapy : CII
Published: October 30, 2024
Positive Lymph Node Status Before and After Neoadjuvant Chemoradiotherapy Improves Prediction of Disease-Free Survival in Esophageal Squamous Cell Carcinoma Patients.
Journal: Annals of surgical oncology
Published: July 29, 2024
Machine learning to predict lymph node metastasis in T1 esophageal squamous cell carcinoma: a multicenter study.
Journal: International journal of surgery (London, England)
Published: March 16, 2024
Nodal Downstaging of Esophageal Cancer After Neoadjuvant Therapy: A Cohort Study and Meta-Analysis.
Journal: Cancer medicine
Published: February 16, 2024
ASO Author Reflections: Exploring the Best Parameter for Lymph Node Assessment in Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.
Journal: Annals of surgical oncology
Published: August 07, 2023
Identification of Optimal Parameters for Assessing Lymph Node Status of Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.
Journal: Annals of surgical oncology
Published: November 14, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026